Search Results

Displaying Results 1-2 of 2 "'TRIT'"

Feb 10, 2026, 10:00 ET Star Gold Corp., Expands Executive Leadership Team

reporting. Netfin raised $254 million in its initial public offering and completed the acquisition of Triterras Fintech Pte. Ltd. (NASDAQ: TRIT) in November 2020, retaining approximately 97% of its original shareholders. Mr. Pascale has also served as CFO and Audit Committee Chairman of NASDAQ-listed

More news about: Star Gold Corp.


Dec 16, 2025, 08:06 ET Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1

of Directors is chaired by industry veteran Keith Katkin, and includes Co-Founder Vivek Ramaswamy; Matthew Hammond, Ph.D., of RA Capital Management; Trit Garg, M.D., of Patient Square Capital; Prisca Di Martino of Abiogen Pharma; and Jay Hagan, Chief Executive Officer."Neridronate is one of the

More news about: Ambros Therapeutics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.